CXCL9 and cancer: identified a novel macrophage polarity signature defined by CXCL9 and SPP1, termed CS-macrophage polarity, which demonstrated a strong association with cancer prognosis and was integrated within a broader network of tumor promoting or suppressing cellular interactions (9).